Skip to main content

Yokogawa establishes innovation center in Allschwil

| News

Yokogawa establishes innovation center in Allschwil

31.07.2020

The Japanese conglomerate Yokogawa has established a Swiss subsidiary based at the Switzerland Innovation Park Basel Area. Here, the focus will be on driving forward innovation in the field of biotechnology.

Yokogawa Innovation Switzerland GmbH is to start business operations in August, as detailed by a press release issued by Yokogawa Electric Corporation. The establishment of the new Swiss subsidiary in Allschwil has come about thanks to the support offered by Basel Area Business & Innovation, the investment and innovation promotion agency. This organization is responsible for operating the Switzerland Innovation Park Basel Area, where Yokogawa is using office and lab space. Yokogawa also opted for Allschwill due to its proximity to Basel, the “European center of the biotechnology and life science industry”, which it describes as an “ideal location”.

In Allschwil, Yokogawa will seek to drive forward innovations in the field of biotechnology. The market for bio-based products is set to continually expand, and for this reason Yokogawa is keen to exploit the expertise and personnel resources on offer in the Basel region in order to “explore new business opportunities, and forge alliances with other entities that have world-leading technologies”, the press release states. In addition, existing activities in the field of industrial automation based in Switzerland will now also be integrated within the new location.

In terms of the future research and development activities in Allschwil, Yokogawa is planning to benefit from Switzerland’s highly competitive position and skilled workforce. Both of these aspects should ensure that Yokogawa is in a position to comply with the Sustainable Development Goals (SDGs) of the United Nations and contribute to the circular economy.

(Read more about starting a business in Switzerland)

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

biGENIUS receives 2 million euros for new cloud product

Software company biGENIUS, based in the Basel Area, has secured financing of 2 million euros. This funding was granted following...
Read More

Opterion Health secures investment of 6.5 million Swiss francs

Opterion Health has raised a total of 6.5 million Swiss francs as part of a financing round. The company, which...
Read More

TOLREMO receives 39 million US dollars in investments

TOLREMO Therapeutics has concluded a series A funding round with 39 million US dollars. The biotech company based in Basel...
Read More

Mazars opens tenth Swiss office in Basel

Mazars is now also present in Basel with a subsidiary as of September 1. This is the tenth Swiss location...
Read More

Medtech in Switzerland – bringing together traditional skills and hightech industry

How the intersection of traditional and novel skillsets in the Jura area is propelling Switzerland into a new era of...
Read More

Fondation Botnar supporting further research into pediatric health

The Basel-based Botnar Research Centre for Child Health has received a further donation of 50 million Swiss francs from the...
Read More

Do you have a question? We'd like to hear from you.